Catalyst Pharmaceuticals, Inc. ( CPRX) - Stock Earnings
CPRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
CPRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 52.8 million USD | 148.4 million USD |
| 2025Q4 | 52.7 million USD | 152.6 million USD |
| 2026Q1 | 63.7 million USD | 149.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CPRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 71.4 million USD | 398.2 million USD |
| 2024 | 163.9 million USD | 491.7 million USD |
| 2025 | 214.3 million USD | 589.0 million USD |
| 2026 Est. | — | — |
CPRX
Price: $31.49
Earnings Per Share: 1.73 USD
P/E Ratio: 18.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -4.3 millionMarket Capitalization: 3.9 billion